ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for SAGE

Stock NameSage Therapeutic
TickerSAGE(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS78667J1088
LEI5493000JX4BJS9W6CN35

Show aggregate SAGE holdings

News associated with SAGE

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Rating of “Reduce” from Brokerages
Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) has been assigned an average recommendation of “Reduce” from the fourteen brokerages that are presently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and thirteen have given a hold rating to the company. The average 12-month price target among […] - 2025-08-25 02:44:49
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Average Rating of “Reduce” by Brokerages
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have received an average rating of “Reduce” from the fifteen ratings firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and fourteen have issued a hold recommendation on the company. The average 1 […] - 2025-07-31 04:24:51
Sage Therapeutics (NASDAQ:SAGE) Cut to Hold at Scotiabank
Scotiabank downgraded shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) from a strong-buy rating to a hold rating in a research report report published on Tuesday morning, MarketBeat.com reports. The brokerage currently has $9.20 target price on the biopharmaceutical company’s stock, down from their prior target price of $12.00. Several other research analysts also recently […] - 2025-07-11 02:10:58
Truist Financial Increases Sage Therapeutics (NASDAQ:SAGE) Price Target to $9.00
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target lifted by Truist Financial from $8.00 to $9.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Truist Financial’s price target suggests a potential downside of 1.42% from the company’s current price. A number […] - 2025-06-19 04:30:53
Sage Therapeutics (NASDAQ:SAGE) Price Target Raised to $8.50
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its price target lifted by analysts at Canaccord Genuity Group from $8.00 to $8.50 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the biopharmaceutical company’s stock. Canaccord Genuity Group’s price target indicates a potential downside of 6.90% from […] - 2025-06-19 02:26:49
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 13:23:43
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 12:54:36
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 12:26:16
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 08:59:17
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 06:48:30
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 03:56:48
Stocks Settle Higher on Possible De-Escalation of Israel-Iran War
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.42%. June E-mini S&P futures (ESM25 ) are up +1.00%, and June E-mini Nasdaq futures... - 2025-06-17 01:58:52
Stocks Rally as Iran Signals it Wants an End to Hostilities
The S&P 500 Index ($SPX ) (SPY ) is up +1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25 ) are up +1.11%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 19:35:01
Stocks Rebound on Hopes Israel-Iran Conflict Will be Contained
The S&P 500 Index ($SPX ) (SPY ) is up +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.98%. June E-mini S&P futures (ESM25 ) are up +0.91%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 18:33:15
Notable Monday Option Activity: SAGE, COST, MSFT
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Sage Therapeutics Inc (Symbol: SAGE), where a total of 9,698 contracts have traded so far, representing approximately 969,800 underlying shares. That amounts to about 13 - 2025-06-16 16:19:49
Stocks Rebound on Hopes Israel-Iran Conflict Will be Contained
The S&P 500 Index ($SPX ) (SPY ) is up +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.98%. June E-mini S&P futures (ESM25 ) are up +0.91%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 14:56:10
Stocks Rally as Iran Signals it Wants an End to Hostilities
The S&P 500 Index ($SPX ) (SPY ) is up +1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25 ) are up +1.11%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 14:39:41
Stocks Rebound on Hopes Israel-Iran Conflict Will be Contained
The S&P 500 Index ($SPX ) (SPY ) is up +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.98%. June E-mini S&P futures (ESM25 ) are up +0.91%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 14:34:20
Stocks Rebound on Hopes Israel-Iran Conflict Will be Contained
The S&P 500 Index ($SPX ) (SPY ) is up +0.79%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.73%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.98%. June E-mini S&P futures (ESM25 ) are up +0.91%, and June E-mini Nasdaq futures (NQM25... - 2025-06-16 12:47:32
Hennion & Walsh Asset Management Inc. Cuts Stock Position in Sage Therapeutics, Inc. (NASDAQ:SAGE)
Hennion & Walsh Asset Management Inc. lessened its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.7% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 14,828 shares of the biopharmaceutical company’s stock after selling 3,418 shares during […] - 2025-06-10 04:58:53
Deutsche Bank AG Buys 20,504 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
Deutsche Bank AG boosted its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 67.6% in the fourth quarter, Holdings Channel reports. The institutional investor owned 50,818 shares of the biopharmaceutical company’s stock after purchasing an additional 20,504 shares during the period. Deutsche Bank AG’s holdings in Sage Therapeutics were worth $276,000 […] - 2025-06-02 04:52:50
Sage Therapeutics (NASDAQ:SAGE) Downgraded by StockNews.com to “Sell”
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Monday. Several other equities research analysts also recently weighed in on SAGE. Wedbush restated a “neutral” rating and issued a $6.00 target […] - 2025-05-21 02:30:50
D. E. Shaw & Co. Inc. Buys 114,173 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
D. E. Shaw & Co. Inc. raised its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 18.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 720,105 shares of the biopharmaceutical company’s stock after purchasing an additional 114,173 shares during […] - 2025-05-19 05:10:59
Algert Global LLC Sells 104,738 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
Algert Global LLC lowered its position in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 73.2% during the fourth quarter, HoldingsChannel.com reports. The fund owned 38,296 shares of the biopharmaceutical company’s stock after selling 104,738 shares during the quarter. Algert Global LLC’s holdings in Sage Therapeutics were worth $208,000 at the end of […] - 2025-05-14 05:59:03
Sage Therapeutics, Inc. (NASDAQ:SAGE) Shares Sold by MetLife Investment Management LLC
MetLife Investment Management LLC lessened its stake in shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 16.5% during the 4th quarter, Holdings Channel reports. The fund owned 25,636 shares of the biopharmaceutical company’s stock after selling 5,076 shares during the quarter. MetLife Investment Management LLC’s holdings in Sage Therapeutics were worth $139,000 at […] - 2025-05-09 05:20:57
Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives $8.81 Average PT from Brokerages
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) have been given a consensus rating of “Hold” by the nineteen ratings firms that are currently covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a sell recommendation, fifteen have given a hold recommendation and two have assigned a buy […] - 2025-03-31 03:04:58
US Bancorp DE Acquires 2,268 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE)
US Bancorp DE raised its stake in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) by 22.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 12,430 shares of the biopharmaceutical company’s stock after buying an additional 2,268 shares during the quarter. US […] - 2025-03-18 05:13:01
Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?
Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE – Get Free Report) passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $6.99 and traded as high as $7.51. Sage Therapeutics shares last traded at $7.27, with a volume of 1,302,493 shares trading hands. Wall Street Analysts Forecast […] - 2025-03-11 05:46:51
Ieq Capital LLC Buys Shares of 10,468 Sage Therapeutics, Inc. (NASDAQ:SAGE)
Ieq Capital LLC purchased a new stake in Sage Therapeutics, Inc. (NASDAQ:SAGE – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 10,468 shares of the biopharmaceutical company’s stock, valued at approximately $57,000. A number of other institutional investors also […] - 2025-03-03 06:50:56
Canaccord Genuity Group Issues Pessimistic Forecast for Sage Therapeutics (NASDAQ:SAGE) Stock Price
Sage Therapeutics (NASDAQ:SAGE – Get Free Report) had its target price reduced by equities researchers at Canaccord Genuity Group from $9.00 to $8.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has a “hold” rating on the biopharmaceutical company’s stock. Canaccord Genuity Group’s target price would suggest a potential upside […] - 2025-02-14 06:40:45

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) SAGE holdings

DateNumber of SAGE Shares HeldBase Market Value of SAGE SharesLocal Market Value of SAGE SharesChange in SAGE Shares HeldChange in SAGE Base ValueCurrent Price per SAGE Share HeldPrevious Price per SAGE Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SAGE by Blackrock for IE00BYXG2H39

Show aggregate share trades of SAGE

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-07-17SELL-224 9.140* 7.23 Profit of 1,619 on sale
2025-07-11SELL-904 9.270* 7.18 Profit of 6,490 on sale
2025-07-07BUY339 9.170* 7.13
2025-07-02BUY6,215 9.080* 7.09
2025-06-25BUY226 9.250* 7.04
2025-06-20BUY2,902 9.300* 6.99
2025-06-11BUY210 6.770* 6.94
2025-06-10BUY210 6.990* 6.94
2025-06-04SELL-106 6.540* 6.94 Profit of 736 on sale
2025-04-23BUY104 7.620* 6.95
2025-04-10SELL-832 6.910* 6.91 Profit of 5,750 on sale
2025-04-08SELL-104 6.390* 6.92 Profit of 719 on sale
2025-04-07SELL-104 6.660* 6.92 Profit of 720 on sale
2025-04-04SELL-520 6.860* 6.92 Profit of 3,598 on sale
2025-04-01BUY424 7.860* 6.90
2025-03-31SELL-315 7.950* 6.89 Profit of 2,170 on sale
2025-03-14SELL-1,696 7.720* 6.72 Profit of 11,389 on sale
2025-03-07SELL-212 7.500* 6.66 Profit of 1,412 on sale
2025-03-04SELL-106 7.320* 6.63 Profit of 703 on sale
2025-02-25BUY212 7.340* 6.58
2025-02-19SELL-106 7.040* 6.54 Profit of 694 on sale
2025-02-13BUY315 7.180* 6.50
2025-02-12BUY105 7.160* 6.49
2025-02-11BUY420 7.190* 6.48
2025-01-17BUY420 7.080* 6.19
2025-01-16BUY420 6.970* 6.17
2025-01-10SELL-212 5.550* 6.08 Profit of 1,290 on sale
2025-01-08SELL-424 5.850* 6.10 Profit of 2,585 on sale
2024-12-30SELL-530 5.430* 6.13 Profit of 3,247 on sale
2024-11-18SELL-1,578 4.780* 6.91 Profit of 10,908 on sale
2024-11-08SELL-105 6.310* 7.04 Profit of 739 on sale
2024-10-21SELL-106 7.790* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SAGE

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-07-301,427,84403,796,31337.6%
2025-07-29516,78102,589,78020.0%
2025-07-28673,64001,828,91636.8%
2025-07-25714,24511,386,13251.5%
2025-07-24179,5260458,41439.2%
2025-07-23540,76101,202,86345.0%
2025-07-221,362,5992,3124,413,23230.9%
2025-07-21252,565351887,07228.5%
2025-07-18216,4310741,82529.2%
2025-07-17166,21997457,82636.3%
2025-07-16250,0800582,53942.9%
2025-07-15193,2460402,91948.0%
2025-07-14317,6550895,52335.5%
2025-07-11304,83901,045,55429.2%
2025-07-1090,7010469,30519.3%
2025-07-09154,3860578,78926.7%
2025-07-08210,9450765,93627.5%
2025-07-07139,9890468,49429.9%
2025-07-03242,94501,400,15517.4%
2025-07-0268,7220688,98010.0%
2025-07-0180,9710289,75327.9%
2025-06-30406,963661,598,57925.5%
2025-06-27491,98403,080,70416.0%
2025-06-26115,2590363,01531.8%
2025-06-25149,5410440,86233.9%
2025-06-24152,8510508,04030.1%
2025-06-23128,077300549,26623.3%
2025-06-20146,145218529,87627.6%
2025-06-18221,63201,081,63220.5%
2025-06-17283,6382811,257,70522.6%
2025-06-161,736,2598,43010,458,81216.6%
2025-06-13133,3290233,20257.2%
2025-06-1273,7950149,09149.5%
2025-06-1154,6510153,90235.5%
2025-06-1081,9912,080347,07423.6%
2025-06-0973,769642134,01855.0%
2025-06-0694,1570277,22634.0%
2025-06-05147,0650274,16853.6%
2025-06-0478,2470138,72056.4%
2025-06-0392,81742202,30145.9%
2025-06-02110,7690211,63252.3%
2025-05-3094,7430204,16346.4%
2025-05-2965,0280137,40347.3%
2025-05-2867,3591160,59641.9%
2025-05-2799,2290207,25247.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy